Neuropeptide Y1 receptor antagonist alleviated osteoarthritis by restoring chondrocyte autophagy through PI3K/AKT/mTOR signaling pathway.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Neuropeptide Y1 receptor antagonist alleviated osteoarthritis by restoring chondrocyte autophagy through PI3K/AKT/mTOR signaling pathway.
- Published In:
- Journal of orthopaedic translation, 55, 146-158 (2025)
- Authors:
- Liu, Song, Wu, Jianqun, Lin, Yucong, Liang, Haifeng, Cai, Yu, Wang, Le, Wang, Zhao, Sang, Hongxun
- Database ID:
- RPEP-12240
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12240APA
Liu, Song; Wu, Jianqun; Lin, Yucong; Liang, Haifeng; Cai, Yu; Wang, Le; Wang, Zhao; Sang, Hongxun. (2025). Neuropeptide Y1 receptor antagonist alleviated osteoarthritis by restoring chondrocyte autophagy through PI3K/AKT/mTOR signaling pathway.. Journal of orthopaedic translation, 55, 146-158. https://doi.org/10.1016/j.jot.2025.08.003
MLA
Liu, Song, et al. "Neuropeptide Y1 receptor antagonist alleviated osteoarthritis by restoring chondrocyte autophagy through PI3K/AKT/mTOR signaling pathway.." Journal of orthopaedic translation, 2025. https://doi.org/10.1016/j.jot.2025.08.003
RethinkPeptides
RethinkPeptides Research Database. "Neuropeptide Y1 receptor antagonist alleviated osteoarthriti..." RPEP-12240. Retrieved from https://rethinkpeptides.com/research/liu-2025-neuropeptide-y1-receptor-antagonist
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.